1. Home
  2. METC vs IRWD Comparison

METC vs IRWD Comparison

Compare METC & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ramaco Resources Inc.

METC

Ramaco Resources Inc.

HOLD

Current Price

$11.82

Market Cap

790.3M

Sector

Energy

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.85

Market Cap

658.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
METC
IRWD
Founded
2015
1998
Country
United States
United States
Employees
900
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
790.3M
658.5M
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
METC
IRWD
Price
$11.82
$3.85
Analyst Decision
Strong Buy
Buy
Analyst Count
8
3
Target Price
$34.00
$7.67
AVG Volume (30 Days)
1.5M
2.7M
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1400.00
EPS
N/A
0.24
Revenue
N/A
$298,276,000.00
Revenue This Year
$19.61
$57.95
Revenue Next Year
$11.96
$4.39
P/E Ratio
N/A
$16.04
Revenue Growth
N/A
8.88
52 Week Low
$11.20
$0.72
52 Week High
$57.80
$5.78

Technical Indicators

Market Signals
Indicator
METC
IRWD
Relative Strength Index (RSI) 38.57 44.24
Support Level $11.34 $3.80
Resistance Level $13.68 $3.95
Average True Range (ATR) 0.83 0.21
MACD -0.02 -0.08
Stochastic Oscillator 20.79 3.77

Price Performance

Historical Comparison
METC
IRWD

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. The company's two operating segments are Metallurgical Coal segment; and Rare Earths and Critical Minerals.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: